Geoffroy Durand
Publications by Year
Research Areas
Renal and related cancers, Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation
Most-Cited Works
- → DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility(2017)210 cited
- → Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids(2019)207 cited
- → Integrative Genome-Wide Gene Expression Profiling of Clear Cell Renal Cell Carcinoma in Czech Republic and in the United States(2013)171 cited
- → Genome-wide association study identifies multiple risk loci for renal cell carcinoma(2017)137 cited
- → MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells(2013)121 cited
- → Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study(2014)108 cited
- → No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing(2016)103 cited
- → Exposure to aflatoxin B1in uterois associated with DNA methylation in white blood cells of infants in The Gambia(2015)97 cited
- → Rare, evolutionarily unlikely missense substitutions in CHEK2contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study(2011)86 cited
- → Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study(2020)83 cited